Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • iltisanni
    Member
    • Mar 2017
    • 21

    MEGAN - species summary

    Hi,

    for those who know the free (community) MEGAN software.

    We sequenced a metagenome and now want to know what species with how many reads were found overall. If possible in a table like this:

    species reads
    Pseudomonas fluorescens 24000
    Escherichia coli 16000
    ... ...

    Does anyone know how to get that information from MEGAN... this software is really complex and confusing imho
    Last edited by iltisanni; 05-16-2018, 09:41 PM.
  • pbm13
    Junior Member
    • Jan 2013
    • 5

    #2
    I have been trying to get similar info out of Megan. I do not know the answer but there is a MEGAN forum called MEGAN community, you might want to try posting there

    Comment

    • iltisanni
      Member
      • Mar 2017
      • 21

      #3
      OK thank you.

      I will try to find an answer there and if I get one I'll post it here aswell.

      Comment

      • iltisanni
        Member
        • Mar 2017
        • 21

        #4
        Still no answer in the community forum but I think I found a workaround:


        uncollapse all, select all leaves, list summary, copy everything into an editor, delete blank lines and replace : by \t -> paste into Excel…

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...